Sort
46,585 grants matching “heart failure”
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,156,801John Peter Wikswo · Vanderbilt University · UH3 · FY2019 · TR
Cohort Analytics Core
$1,156,714Joshua Denny · National Human Genome Research Institute · ZIC · FY2024 · HG
Health Outcomes of Weight loss: Look AHEAD -Action for Health in Diabetes
$1,156,667Robert W Jeffery · University Of Minnesota · U01 · FY2012 · DK
Cardiovascular Engineering Science
$1,155,645University Of California San Diego · T32 · FY2005 · HL
PREcision Care In Cardiac ArrEst - ICECAP (PRECICECAP)
$1,155,493Karen G Hirsch · Stanford University · R01 · FY2024 · NS
Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure
$1,154,707Dale Murray Needham · Johns Hopkins University · R24 · FY2015 · HL
Human Cardio-Pulmonary System on a Chip
$1,154,347Kevin Kit Parker · Harvard Medical School · UH3 · FY2014 · TR
CORAL: Data Coordinating Center
$1,154,059Donald Cutlip · Beth Israel Deaconess Medical Center · U01 · FY2010 · HL
Long-Term Neural Determinants of Cardiovascular Diseases
$1,154,053John W Osborn · University Of Minnesota · R01 · FY2009 · HL
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium
$1,152,935Edward D Siew · Vanderbilt University Medical Center · U01 · FY2025 · DK
HCMR Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
$1,151,474Christopher M Kramer · University Of Virginia · U01 · FY2015 · HL
Executing the IND-Enabling Studies for Oral PCSK9/LDLR antagonist
$1,150,186Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2025 · HL
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,149,938John Peter Wikswo · Vanderbilt University · UH3 · FY2020 · TR
A cross-species preclinical platform to enhance the translation of new medicines
$1,149,771Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2025 · TR
San Diego EXPORT Comprehensive NCMHD Research Center
$1,149,623Sandra P Daley · University Of California, San Diego · P60 · FY2008 · MD
Project 2: Menopause, Midlife and Cardiovascular Health in Early Old Age
$1,149,549Rebecca C Thurston · University Of Pittsburgh At Pittsburgh · U19 · FY2024 · AG
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,149,180John Peter Wikswo · Vanderbilt University · UH3 · FY2021 · TR
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,146,280John Peter Wikswo · Vanderbilt University · UG3 · FY2017 · TR
IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia
$1,145,632Meredith Hay · University Of Arizona · U01 · FY2022 · AG
Urgent and unmet need for a long-term solution for increasing pediatric heart-failure population: BiVACOR Rotary Total Artificial Heart
$1,145,601Daniel Timms · Bivacor, Inc. · R44 · FY2022 · HL
NEUROCIRCULATORY FUNCTION IN CHRONIC HEART FAILURE
$1,145,588University Of Nebraska Medical Center · P01 · FY2002 · HL
CHS Events Follow-up Study
$1,145,576Bruce M Psaty · University Of Washington · U01 · FY2007 · HL
Pathogenesis and Diagnosis of Multiple System Atrophy (P01)
$1,144,456Phillip A Low · Mayo Clinic Rochester · P01 · FY2011 · NS
NHGRI/DIR Genomics Core
$1,144,148Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2025 · HG
New Magnetically Suspended LEV-VAD
$1,144,139Don B. Olsen · Utah Artificial Heart Institute · R01 · FY2007 · HL